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ABSTRACT 
A new block polymer named poly 3-acrylamidophenylboronic acid-b-6-O–vinylazeloyl-D 
-galactose (p(AAPBA-b-OVZG)) was prepared using 3-acrylamidophenylboronic acid (AAPBA) 
and 6-O-vinylazeloyl–D-galactose (OVZG) via a two-step procedure involving S-1-dodecyl-S-(α′, 
α′-dimethyl-α″-acetic acid) trithiocarbonate (DDATC) as chain transfer agent, 
2,2-azobisisobutyronitrile (AIBN) as initiator and dimethyl formamide (DMF) as solvent. The 
structures of the polymer were examined by Fourier transform infrared spectroscopy (FT-IR) and 
1
H-NMR and the thermal stability was determined by thermal gravimetric analysis (TG/DTG). 
Transmission electron microscopy (TEM) and dynamic light scattering (DLS) were utilized to 
evaluate the morphology and properties of the p(AAPBA-b-OVZG) nanoparticles. The cell 
toxicity, animal toxicity and therapeutic efficacy were also investigated. The results indicate the 
p(AAPBA-b-OVZG) was successfully synthesized and had excellent thermal stability. Moreover, 
the p(AAPBA-b-OVZG) nanoparticles were submicron in size and glucose-sensitive in 
phosphate-buffered saline (PBS). In addition, insulin as a model drug had a high encapsulation 
efficiency and loading capacity and the release of insulin was increased at higher glucose levels. 
Furthermore, the nanoparticles showed a low-toxicity in cell and animal studies and they were 
effective at decreasing blood glucose levels of mice over 96h. These p(AAPBA-b-OVZG) 
nanoparticles show promise for applications in diabetes treatment using insulin or other 
hypoglycemic proteins. 
Keywords: 3-Acrylamidophenylboronic Acid (AAPBA), 6-O-vinylazeloyl-D-galactose (OVZG), 
Nanoparticles (NPs), Glucose-Sensitive, Insulin Delivery. 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
 
 3 
1. Introduction 
Epidemiological investigations have shown that in 2011 there were about 366 million 
diabetics worldwide and about 1.3 million diabetes patients died which is twice the figure seen in  
1990 [1]. Moreover, the incidences of diabetes and mortality rates have continued to increase over 
the last 5 years [2-4]. Thus, there is little doubt that diabetes has become a serious disease that 
affects many, otherwise healthy people, and new methodology of controlling blood sugar levels is 
desperately needed for diabetes patients [5]. Generally speaking, there are three methodologies 
used in the treatment of diabetes: primary prevention measures; healthy lifestyle changes; and 
long term management [6]. Primary prevention measures and healthy lifestyle changes usually 
involve increasing physical exercise and diet control. Long term management of diabetes involves 
intensive glycemic control utilizing drugs such as epaglinide, insulin, liraglutide, metformin, 
acarbose, or rosiglitazone hydrochloride [7-9] although insulin is still the most effective and 
cheapest drug. However patients have different body weights and variable glucose levels, so the 
required dose of insulin needed to return their glucose levels to normal can vary widely. Also there 
is the issue of injecting too much insulin resulting in hypoglycemia or too little leading to rapid 
heartbeat and polyuria
 
[10-11]. Consequently the development of a smart response system is 
highly desirable.  
In recent years, functional biological materials have been studied extensively in drug delivery 
systems, due to their low price and excellent biocompatibility and they have shown great promise 
[12-14]. Glucose-responsive delivery systems based on biological materials have rarely been 
reported [15-18]. Those that have been described are usually based on phenylboronic acid (PBA) 
and/or derivatives of phenylboronic acid. For example, Wang et al.
 
[19] used a two-step template 
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polymerization to prepare new temperature- and glucose-responsive nanogels based on poly 
(N-isopropyl-acrylamide) and poly-(N-phenylboronic acid-acrylamide). They found that these 
nanogels had interpenetrating polymer networks and good glucose response. Also Sun et al.
 
[20] 
prepared poly(N-isopropylacrylamide-co-3-acrylamidophenylboronic acid -co-dextran-maleic acid) 
coated silica nanoparticles via radical polymerization and found the cumulative release of insulin 
in vitro was dependent on glucose concentration. In addition, previously, we reported [21] the 
synthesis of a new temperature-sensitive copolymer named p(NVCL-co-AAPBA) from 
N-vinylcaprolactam (NVCL) and 3–acrylamido phenylboronic acid (AAPBA) and found that it    
had excellent glucose-response. However, all the previous work [19-21] resulted in compounds 
having a short duration of activity (8-48h) due to degradation of the nanoparticles based on 
phenylboronic acid and consequently required frequent injections which brings new problems, so 
it is imperative to develop products that release insulin when required. 
Glycopolymers are a type of functional polymeric material synthesized using different 
biological and chemical reactions, which maintain the special properties of sugars, but also have 
some new functionalities such as good hydrophilicity, biocompatibility and biodegradability [22]. 
Guo et al.
 
[23] described the synthesis of a block and random co-polymer based on the PBA and 
glycopolymers using
 
the phenylboronic acid-based glycopolymer poly(3-acrylamido 
-phenylboronic acid-b-2-acrylamido glucopyranose) p(AAPBA-b-AGA) and found that the 
nanoparticles had a high glucose-response but had the disadvantage of having a cumulative release 
time of only 16 h. Galactose and glucose can also react with diolefinic acid to produce compounds 
containing a single olefinic acid which can be formed into glycopolymers by polymerization. Thus, 
Kan Sun et al.
 
[24] synthesized poly(N-isopropylacrylamide-co-6-O-vinyladipoyl -D-glucose)-b 
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-poly(N-isopropylacrylamide) and found that the pendant glucose moeties had obvious interaction 
with lectin and concanavalin A (Con A). Due to the compound containing fructose, galactose and 
glucose it is easy to form a glycopolymers [25], so it is to be expected that AAPBA will react with 
glycopolymers containing fructose, galactose or glucose to form a new copolymer which may be 
responsive to glucose levels in blood, and further increase the cumulative release times.  
In this work, a new glycopolymer, 6-O-vinylazeloyl-D-galactose (OVZG) was first 
synthesized and this was then combined with PBA to give a glucose sensitive polymer poly 
6-O-vinylazeloyl-D-galactose-b-3-acrylamidophenylboronic acid (p(AAPBA-b-OVZG)). 
Thereafter, in vitro studies on the insulin loading, encapsulation and release from the nanoparticles 
were performed and their toxicology was examined both in vitro and in vivo. Finally, the 
therapeutic effects of the formulations were assessed using a mouse model of diabetes. We believe 
that the stimuli-responsive systems described in this work may have great potential for the 
development of advanced insulin delivery systems. 
2. Materials and Methods 
2.1. Materials  
3-Acrylamidophenylboronic acid (AAPBA) was purchased from the Beijing Pure Chem. Co., Ltd. 
(Beijing, PR China) and alkaline protease (from Bacillus subtilis, 100 U per mg) was obtained 
from the Wuxi Xue Mei Co. Ltd. (EC 3.4.21.14, Wuxi, PR China). Azelaic acid was purchased 
from the Sinopharm Chemical Reagent Co. (Shanghai, PR China); S-1-dodecyl-S-(α′, 
α′-dimethyl-α″-acetic acid) trithiocarbonate (DDATC) was obtained from Sigma-Aldrich Trading 
Co., Ltd.; 2-[4-(2-Hydroxyethyl)-1-piperazinyl] ethanesulfonic acid (HEPES) was procured from 
the Nanjing Robiot Co. (Nanjing, PR China). Dimethylformamide (DMF), dimethyl sulfoxide 
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(DMSO) and 2,2-azobisisobutyronitrile (AIBN) was purchased from the Sinopharm Chemical 
Reagent Co., Ltd. (Shanghai, PR China). All solvents used in this work were analytical grade.  
2.2. Synthesis of p(AAPBA-b -OVZG). 
2.2. 1 Synthesis of 9-O-viny azelaicoyl-D-galactose (OVZG).  
OVZG was synthesized as previously reported [26] via the chemoenzymatic route.  
2.2.2. Synthesis of poly(3-acrylamidophenylboronic acid) (pAAPBA).  
The synthesis of pAAPBA was based on a previous method [27] using AAPBA (300 mg), DDATC 
(3 mg), AIBN (0.3 mg) and N,N-dimethylformamide (DMF; 1 mL) as solvent. The reaction 
mixture was sealed in a reaction vessel (50 mL) and was subjected to three freeze–thaw cycles 
under vacuum. The reaction vessel was then placed in a preheated oil bath (70
 o
C) for 8 hours and 
then cooled in ice water for 5 min. The resultant polymer was precipitated by pouring the solution 
into diethyl ether, filtered and washed with acetone and dried under vacuum. 
2.2.3. Synthesis of p(AAPBA-b-OVZG).  
p(AAPBA-b-OVZG) was prepared via RAFT copolymerization, using OVZG as a monomer, the 
homopolymer pAAPBA as a macro RAFT agent, AIBN as the initiator, and DMF as the solvent. 
The reaction mixture was sealed in a reaction vessel (50 mL) and was subjected to three 
freeze–thaw cycles under vacuum. And then the same procedure as described above (2.2.2. 
Synthesis of poly(3-acrylamidophenylboronic acid) (pAAPBA)) was followed. By changing the 
ratio of pAAPBA to OVZG, five different glycopolymers were prepared and named as 
p(AAPBA-b-OVZG)1, p(AAPBA-b -OVZG)2, p(AAPBA-b-OVZG)3, p(AAPBA-b-OVZG)4 and 
p(AAPBA-b-OVZG)5. 
2.3. Characterization of the polymers 
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The polymers were characterized using Fourier transform infrared spectroscopy (FT-IR), 
thermogravimetric analysis, 
1
H-NMR and Gel Permeation Chromatography (GPC). As previously 
reported [24], FT-IR spectra were recorded on a Fourier Transform Infrared Spectrometer 
(FTS-6000, Bio-Rad Co.) at a resolution of 2 cm
-1
, using a KBr solid solution. The 
thermogravimetric analysis of the copolymer was conducted with a thermogravimetric analyzer 
(TGA, STA409PC), where the sample (3-5 mg) was heated at a rate of 10 °C/min in a nitrogen 
atmosphere. 
1
H-NMR spectra were obtained using purified polymer samples (3-5mg) in 
D2O+NaOD (1mL, pH=9.0) with a Bruker DRX 400 MHz spectrometer (Bruker, Rheinstetten, 
Germany). The molecular weights (Mw and Mn) and molecular weight distributions of the 
polymers were determined by GPC measurements on a Waters LS system.  
2.4 Preparation of Nanoparticles (NPs) 
P(AAPBA-b-OVZG) NPs were prepared according to a previously reported method [28] using  
p(AAPBA-b-OVZG) (10 mg) dissolved into dimethyl sulfoxide (DMSO) and water (2 mL; 1:1 
v/v). This solution was added dropwise into ultra-pure water (20 mL) with stirring (300r/min). 
After 3h, the suspension was centrifuged (10min; 12000r/min), the supernatant discarded and then 
ultra-pure water (20mL) was added. The resulting suspension was transferred to a dialysis tube 
(MWCO 8000) and dialyzed against water for 72 h with the water being replaced every 4 h in 
order to remove the organic solvent. The suspension was then vacuum freeze dried to give pure 
NPs.  
In order to prepare the insulin-loaded NPs, insulin (500 µg) was dissolved in a sodium acetate 
solution (20 mL; 0.5%) and the solution of the NPs was added dropwise as described above.  
After dialysis for 72 h, the suspension of insulin-loaded NPs was centrifuged at 12000 rpm for 20 
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min and the amount of free insulin in the supernatant was measured using the Bradford method 
with a UV spectrometer (Shimadzu UV-2550) at 595 nm. The insulin Encapsulation Efficiency 
(EE) and Loading Capacity (LC) were calculated according to the following equations: 
EE% = (total insulin-free insulin)/total insulin×100 
LC% = (total insulin-free insulin)/NPs weight×100 
2.5 Transmission Electron Microscopy (TEM).  
The TEM micrographs were obtained using a transmission electron microscope (JEM-2100, JEOL, 
Japan). The samples were prepared by placing a drop of the p(AAPBA-b-OVZG) ultra-pure water 
solution (0.3 mg/mL) onto a copper grid and drying at 36 
o
C. 
2.6 Reversible pH and glucose sensitivity of the NPs 
The pH and glucose sensitivity were determined by using the blank p(AAPBA-b-OVZG) NPs. 
The pH sensitivity was measured by suspending the pure NPs (10 mg) in ultra-pure water (25 mL) 
at pH 5.0, 5.5, 6.0, 6.5, 7.0, 7.5, 8.0, 8.5 and 9.0 for 0.5 h. The size of the NPs was measured by 
dynamic light scattering (DLS, Malvern Zetasizer Nano S apparatus equipped with a 4.0 mV laser 
operating at λ=636 nm) at 37 
o
C.  
Glucose sensitivity was determined by using the blank NPs (10mg) with 0, 1.0, 2.0, and 3.0 
mg/mL glucose in PBS (25mL) for 0, 10, 20, 30, 40, 50 and 60 min, and then the size of the NPs 
was measured by DLS at 37 
o
C.  
2.7 In vitro release behavior 
In order to determine the in vitro release, the different insulin-loaded NPs (5 mg) were mixed with 
PBS (20 mL; 0.1 M, pH=7.4) containing different glucose concentrations (0, 1, 2 and 3 mg/mL) 
and shaken (100r/min) at 37 
o
C. After a predetermined time, an aliquot of supernatant (1 mL) was 
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removed and fresh buffer solution was added. The amount of free insulin was monitored by UV 
spectrophotometry with each sample being analyzed in triplicate and the results reported as the 
mean
 ±standard deviation (n=3). 
2.8 Toxicity 
2.8.1 Cell viability study and MTT assays. 
The MTT assay was used to evaluate the cell viability of the p(AAPBA-b-OVZG) NPs with NIH 
3T3 cells cultured in a modified Dulbecco Eagle’s medium (DMEM, Gibco) in a humidified 
atmosphere of 5 % CO2. The cells were seeded into 96-well plates at a density of 1×10
4
cells per 
well and suspensions of p(AAPBA-b-OVZG) NPs (100 mL) with concentrations ranging from 20 
to 120 mg/mL were added and incubated for 24 h. Then MTT solution in PBS buffer (20 L; 5 
mg/mL) was added to each well and then removed four hours later. The samples in the wells were 
allowed to dry naturally for 4h, DMSO (200 uL) was added to dissolve the formed crystals and the 
optical density of the solution was measured at 570 nm using a microplate reader (Thermo 
Multiskan MK3, Thermo Scientific Company, Waltham, UK). The NIH 3T3 cells without any 
treatment were used as the control. 
2.8.2 Acute animal toxicity 
A total of 24 Kunming mice (12 males and 12 females; 19-23 g) were obtained from the Animal 
Center of Kunming Medical University (Kunming, China). All the mice were given 2 weeks 
adaptive feeding, and then were randomly divided into the control group and the experimental 
groups (low, middle and high doses, n=6). After 2 weeks, the control group was injected with 
saline solution (1 mL/d) intraperitoneally, and the low, middle and high dose group were given 
p(AAPBA-b-OVZG)4 NPs (100 mg/kg/d, 200 mg/kg/d and 400 mg/kg/d respectively) using the 
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same method. After 7 days, all the mice were sacrificed and their livers, kidneys, spleens, hearts 
and lungs were collected for Hematoxylin and Eosin (HE) staining in order to detect if any 
visceral damage had occurred. 
2.8.3 Chronic toxicological experiments 
A total of 24 Kunming mice (12 males and 12 females; 19-23 g) were divided into the control 
group (n=6) and the experimental groups (10, 20 and 40 mg/kg/d-dose) randomly. The 
experimental mice received intraperitoneal injections with the appropriate doses of 
p(AAPBA-b-OVZG)4 NPs and the control group received injections of saline solution (1 
mL/kg/d). After 60 days, the mice were sacrificed, their blood was collected and the 
concentrations of Red Blood Cells (RBC), White Blood Cells (WBC), Platelet, Hemoglobin, 
Serum protein, Serum creatinine, Hematocrit, Serum glutathione, Total cholesterol, Glucose, Uric 
acid, Aspartate aminoTransferase (AST) and Glutamine Transaminase (ALT) were determined 
using an automated Olympus AU5400 biochemistry analyzer (Olympus, Tokyo, Japan). 
2.9 In vivo hypoglycemic experiments 
All the diabetes mellitus mice (fasting blood glucose levels >15.6 mmol/L, n=18) were provided 
kindly by the College of Basic Medical Sciences of Kunming Medical University and were 
randomly allocated into a high fat group (n=6), an insulin injection group (n=6) and a 
p(AAPBA-b-OVZG)4 group (n=6) and six other healthy mice were chosen as a control group 
(CG). The mice in the p(AAPBA-b-OVZG) group received insulin-loaded p(AAPBA-b-OVZG)4 
NPs (1 mL/kg, contained 1.0 mg insulin, the solvent was 0.6% normal saline) injections, those in 
the insulin injection group received insulin injection (1 mL/kg, contained 0.16 mg insulin, the 
solvent was 0.6% sodium acetate solution) and the remaining mice in the high fat group and in the 
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control group were given distilled water (0.5 mL/kg) injection every day. The blood of mice was 
collected from tail veins and the blood glucose levels were measured by a Blood Glucose Meter 
((GT-1640); Jiangxi Jingdou Co., Ltd. Nanchang, PR China). In addition, the blood was 
centrifuged (3000 rpm, 10 min), the supernatant collected and the insulin level was determined at 
0h, 1h, 2h, 3h, 4h, 5h, 6h, 12h, 24h, 36h, 48h, 60h, 72h, 84h, 96h, 108h and 120h using an 
appropriate insulin ELISA kit (China Institute of Atomic Energy, China). All the animal 
experimental operations were in line with the Guide for the Care and Use of Laboratory Animals 
published by the US National Institutes of Health (NIH Publication No. 8523, revised 1985) and 
all the experiments were approved by the Animal Care and Use Committee of Kunming Medical 
University (certificate number: KMMU 2014002). 
 
3 Results 
3.1 Characterization of the Block and Random Copolymers.  
The p(AAPBA-b-OVZG) glycopolymers were synthesized in good yields (Table 1) via a 
sequential RAFT polymerization process (Scheme 1 and Scheme 2) .  
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Tab.1. Constitution and yield of the copolymers 
Sample Monomer (mol/mol) yield (%) 
p(AAPBA-b-OVZG)1 OVZG/AAPBA =100: 10 65.43 
p(AAPBA-b-OVZG)2 OVZG/AAPBA =100: 20 72.62 
p(AAPBA-b-OVZG)3 OVZG/AAPBA =100: 50 69.37 
p(AAPBA-b-OVZG)4 OVZG/AAPBA =100: 100 70.56 
p(AAPBA-b-OVZG)5 OVZG/AAPBA =100: 200 74.29 
Note: yield was calculated via weight method. 
 
 
Scheme 1. The synthesis of OVZG by controllable chemo enzymatic reaction. 
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Scheme 2. The synthesis of p(OVZG-b-AAPBA) by RAFT polymerization. 
 
The FT-IR spectra of AAPBA, OVZG, p(AAPBA) and p(AAPBA-b-OVZG)4 are shown in Fig.1. 
AAPBA displays four characteristic absorption bands: C=O str. at 1660 cm
-1
, C=C str. at 1620 
cm
-1
, O-B-O at 1352 cm
-1
 and B-O at 1014 cm
-1
. The benzene ring skeleton is present between 
1555-1610 cm
-1
 and the meta-substituted benzene absorptions are at 698 cm
-1
 and 791 cm
-1
.  
OVZG shows C=O str. at 1740 cm
-1
, C=C str. at 1650 cm
-1
, -NH str. at 1490 
-1
 and the absorption 
at 1920 cm
-1
 is the overtone 960 cm
-1
. In p(AAPBA) and p(AAPBA-b-OVZG)4, the absorption 
due to C=C disappears indicating that successful polymerization had occurred and in the FT-IR 
spectrum of p( APBA-b-OVZG)4 there exists B-O str. at 996 cm
-1
, which proves AAPBA had 
been incorporated into the polymer. 
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Fig.1. FT-IR spectra of (A) OVZG, (B) AAPBA, (C) pAAPBA and (D) p(AAPBA-b-OVZG)4 
 
Figure 2 shows the 1H-NMR spectra of OVZG, AAPBA, p(AAPBA) and p(AAPBA-b-OVZG)4. 
The spectrum of OVZG (Figure 2A) (D2O+ DMSO-d6) δ：6.95(1H, 3-H), 6.35(1H, 8-H), 4.75(2H, 
1-H), 4.65 (1H, 2-H), 4.55(2H, 7-H), 4.15 (1H, 6-H), 3.95 (1H, 5-H) and 3.45 (1H, 4-H). AAPBA 
(Figure 2B) shows the following assignments: 1H NMR (NaOD+D2O; pH = 9.5): δ: 10.09 (1H, 
4-H), 8.10-7.25 (the H of benzene ring), 6.47 (1H, 2-H), 6.20 (1H, 3-H) and 5.75 (2H, 1-H). 
p(AAPBA) (Figure 2C) (NaOD+D2O; pH = 9.5) δ: 8.40-6.33 (the H of benzene ring), 2.95 (2H, 
10-H), 2.14 (1H, 4-H), 1.75 (1H, 9-H), 0.50-1.25 and 2.33 (the C12H25, 1-H, 2-H and 3-H) and the 
p(AAPBA-b-OVZG)4 (Figure 2D) (NaOD+D2O; pH = 9.5) δ: 8.10-7.15 (the H of benzene ring), 
5.05 (1H, 4-H), 4.05(1H, 5-H) , 3.45-3.75(the H of (CH2)7, 3-H), 3.25 (4H, 2-H), 2.80(1H, 7-H), 
2.65(1H, 1-H), 1.65(2H, 8-H) and 1.75 (2H, 6-H). Compared with the spectra of the monomers 
AAPBA and OVZG, it is obvious that the peaks of ethylene in p(AAPBA) and 
p(AAPBA-b-OVZG)4 have disappeared and the peaks of these protons can be assigned in the 
structure of p(AAPBA-b-OVZG)4. The H of benzene ring in p(AAPBA) and 
p(AAPBA-b-OVZG)4 have slightly different chemical shifts compared to a previous report [23], 
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which may be due to the different solvent used  
 
  Fig.2. 1H NMR spectra of (A) OVZG, (B) AAPBA, (C) pAAPBA and (D) p(AAPBA-b-OVZG)4.  
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Figure 3 shows the thermogravimetric (TG) and derivative thermogravimetric (DTG) curves for 
pAAPBA and p(AAPBA-b-OVZG)4. For DTG curves, it can be seen that there are three 
degradation stages at about 66 °C, 361 °C and 409 °C for p(AAPBA), and 195 °C, 349 °C and 
418°C for p(AAPBA-b-OVZG)4. For p(AAPBA-b-OVZG)4, the first peak at 195 °C is assigned 
to loss of free water and water linked through hydrogen bonds. The second peak, which has a 
maximum around 361 °C for p(AAPBA) and 349 °C for p(AAPBA-b-OVZG)4, corresponds to 
the thermal decomposition of the pendent residues. The last degradation stage involves thermal 
degradation of the backbone and shows a peak at 409 °C for p(AAPBA) and 418 °C for 
p(AAPBA-b-OVZG)4 . These results are consistent with previous reports [29] and show that the 
copolymer structure plays an important role in their thermal decomposition and stability. 
 
 
Fig.3. Thermal analysis of the copolymers: (A) DTG and (B) TG.  
 
The molecular weights of the polymers determined by GPC are summarized in Table 2.  It was 
found that a higher p(AAPBA) ratio in the p(AAPBA-b-OVZG) co-polymer leads to an increase 
of Mw, Mn and PDI.  This was also found in our previous work [21], where the new compound 
p(N-vinylcaprolactam-co-3-acrylamidophenylboronic acid) had higher Mw, Mn and PDI as the 
proportion of AAPBA increased.  
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Table2.  The molecular weights (Mw and Mn) and molecular weight distributions of the copolymers  
Sample OVZG/(pAAPBA) Mw Mn PDI 
p(AAPBA-b-OVZG)1 100/10 66754 54202 1.23 
p(AAPBA-b-OVZG)2 100/20 69568 56572 1.23 
p(AAPBA-b-OVZG)3 100/50 71348 58792 1.21 
p(AAPBA-b-OVZG)4 100/100 78522 64892 1.21 
p(AAPBA-b-OVZG)5 100/200 84892 70454 1.20 
 
3.2 Nanoparticle characterization 
Photographs of suspensions of the different p(AAPBA-b-OVZG) NPs (1mg/mL) and the TEM 
images of all the NPs can been seen in the Fig.S1 and the degradation characteristics of the 
polymers in vitro at 37 °C can be seen in Fig S3. In addition, Fig. 4 indicates that the size of the 
blank NPs (no insulin) change very little over 6 weeks, indicating that p(AAPBA-b-OVZG) NPs 
are stable in aqueous solution.  Fig S2 illustrates the change in hydrodynamic diameters at 
different pH values indicating the optimal ratio of OVZG to p(AAPBA) NPs.  
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Fig.4. The stability of blank p(AAPBA-b-OVZG) NPs in pH 7.4 PBS. 
 
Moreover, it was found that with the increase of the p(AAPBA) ratio in the p(AAPBA-b-OVZG) 
co-polymer, the Zeta potential (determined with a submicron particle size analyzer; 
ZetaPALS/90plus, Brookhaven Instruments Corporation, Holtsville, NY, USA) was decreased 
from -21.4 to -36.3 and this trend has been observed previously [29-30].  Overall, the 
nanoparticles become more and more stable with a higher proportion of p(AAPBA). (Table 3).  
Tab.3. The zeta potentials of the copolymer NPs. 
Samples OVZG/(pAAPBA) Zeta potential (mV) 
p(AAPBA-b-OVZG)1 100/10 -21.4±2.3 
p(AAPBA-b-OVZG)2 100/20 -26.9±1.8 
p(AAPBA-b-OVZG)3 100/50 -33.6±1.7 
p(AAPBA-b-OVZG)4 100/100 -34.2±0.9 
p(AAPBA-b-OVZG)5 100/200 -36.3±1.2 
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The mechanism proposed for the glucose-responsive nature of the materials is summarized in 
Scheme 3. 
 
Scheme 3.  Schematic representation of nanoparticles 
 
Fig. 5 shows the hydrodynamic diameters of nanoparticles in the glucose medium (on the left) and 
the values of I/I0 versus time in pH 7.4 PBS (on the right).  They were measured by DLS where I 
represent the light scattering intensity and I0 is the control value of the nanoparticles in the 
absence of glucose.  The values of I/I0 agree with previously reported data on the nanoparticle 
swelling degree in different glucose media [31].  From Fig.5 A1 to Fig.5 A5 it can be seen that in 
the absence of glucose the hydrodynamic diameters do not change much over 60 min but as the 
glucose concentration is increased there is a trend toward bigger diameters as the amount of 
pAAPBA present is increased.  Fig.5 B1 to Fig.5 B5 shows, that there is a decreasing trend in the 
I/I0 ratio as the glucose concentration was changed from 0 to 3 mg/mL.  The reduction in the I/I0 
values was greater in the 3 mg/mL glucose medium than in 0 mg/mL for each type of nanoparticle 
due to more dissociation of nanoparticles at higher glucose concentration [32]. Furthermore, the 
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pattern of the hydrodynamic diameter enhancement showed the glucose sensitivity since the 
glucose combined with the boronic acid moieties forming a boronate complex [33], which was 
dynamically-covalent, and allowed the linkage to reconfigure in presence of other polyols such as 
glucose.  Interestingly, p(AAPBA-b-OVZG)5 showed hardly any change in size compared with 
p(AAPBA-b-OVZG)4 possibly due to the fact that the AAPBA in p(AAPBA-b-DEGMA)5 cannot 
be ionized any further.   
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Fig.5. Changes in the size of the p(AAPBA-b-OVZG) nanoparticles as a function of immersion time in pH 7.4 
PBS solutions of glucose. (1) p(AAPBA-b-OVZG)1; (2) p(AAPBA-b-OVZG)2; (3) p(AAPBA-b-OVZG)3; (4) 
p(AAPBA-b-OVZG)4; (5) p(AAPBA-b-OVZG)5. The graphs on the left (marked A) show the hydrodynamic 
diameters, while those on the right (marked B) show I/I0  
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Fig. 6 illustrates that the glycopolymers show reversible glucose sensitivity.  All of the 
p(AAPBA-b-OVZG) samples swelled after the first treatment with 3 mg/mL glucose for 4h, and 
then they contracted virtually to their original size when placed in water containing no glucose. 
When treated with glucose (3 mg/mL) for the second time, the NPs swelled again and returned to 
a size, which was close to the first swelling. 
 
 
Fig.6. Reversible glucose sensitivity of p(AAPBA-b-OVZG) NPs. 
 
3.4 Insulin loading and release 
The self-assembly process can be influenced by hydrophobic–hydrophilic interactions, 
electrostatic interactions, hydrogen bonding and other intermolecular interactions [34].  Insulin, a 
protein containing numerous amino acids, has hydrophilic and hydrophobic residues and can form 
stable complexes due to the above interactions [35].  Thus, when added to p(AAPBA-b-OVZG) 
suspension of nanoparticles and coupled with the amphiphilic glycopolymer, insulin can be loaded 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
 
 23 
onto the glycopolymer NPs via hydrogen bonding, van der Waals forces and 
hydrophilic–hydrophobic interactions [36].  The results in Table 4 show that insulin was easily 
attached to the p(AAPBA-b-OVZG) NPs and the loading capacity of insulin was about 10% for 
all NPs and the encapsulation efficiency of insulin increased from 53.2% to 63.8% as the ratio of  
pAAPBA was raised.  
Tab.4. Insulin loading capacity and encapsulation efficiency of p(AAPBA-b-OVZG) NPs 
Samples LC% EF% 
p(AAPBA-b-OVZG)1 9.81+3.43 58.49+2.41 
p(AAPBA-b-OVZG)2 10.23+2.87 60.22+3.26 
p(AAPBA-b-OVZG)3 11.36+3.01 57.52+1.92 
p(AAPBA-b-OVZG)4 11.42+2.85 64.31+3.14 
p(AAPBA-b-OVZG)5 11.22+3.23 55.33+2.76 
 
All of the p(AAPBA-b-OVZG) NPs were able to detect the amount of insulin release at different 
glucose concentrations.  It can be seen from Fig.7A that the cumulative release of insulin from 
the p(AAPBA-b-OVZG)4 NPs increased at higher glucose concentrations and Fig.7B shows that 
the best results are obtained using p(AAPBA-b-OVZG)4 NPs in 3mg/mL glucose solution. It can 
also be seen that the release of insulin continues for around 120 h and compared with the reports 
of Yao et al. and Arjyabaran Sinha et al. [36-37] this is a considerable enhancement. Yao et al. 
fabricated [37] the amphiphilic block copolymer poly(ethylene 
glycol)-block-poly((2-phenylboronic ester-1,3 -dioxane-5-ethyl) methylacrylate) 
(MPEG5000-b-PBDEMA) via atom transfer radical polymerization (ATRP) using MPEG5000-Br 
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as a macroinitiator and found the time of cumulative release of insulin was reached at 60 h in 3 
mg/mL of glucose solution.  Arjyabaran Sinha et al. [38] designed a phenylboronic acid 
functionalized MMS (MMS-PBA) but found the time of cumulative release was only 8 h in 
3mg/mL of glucose solution.  
 
 
Fig.7. In vitro cumulative release of insulin in pH 7.4 PBS from: (A) p(AAPBA-b-OVZG)4 in different 
concentrations of glucose in solution, and (B) p(AAPBA-b-OVZG)1, p(AAPBA-b-OVZG)2, 
p(AAPBA-b-OVZG)3, p(AAPBA-b-OVZG) 4 and p(AAPBA-b -OVZG)5 in 3 mg/mL glucose solution. 
 
In order to elucidate the insulin release mechanism, the results were analyzed in the light of the 
Ritger-Peppas equation. R
2
 values higher than 0.9 were obtained and the values of n were in the 
range 0.29−0.54 (Table 5) indicating that insulin release was mainly due to non-Fickian diffusion. 
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Tab.5. Drug Release Kinetic Data for the Copolymer Nanoparticles Obtained from Fitting Drug Release Data to 
the Ritger-Peppas Equation (where n is the diffusion exponent; k is the kinetic constant; R2 is correlation 
coefficient.) 
samples 
glucose concentration 
(mg/mL) 
Ridger-Peppas model 
transport mechanism 
n k R2 
p(AAPBA-b-OVZG)1 3 0.2943 23.816 0.9789 non-Fickian diffusion 
p(AAPBA-b-OVZG)2 3 0.3901 26.606 0.9267 non-Fickian diffusion 
p(AAPBA-b-OVZG)3 3 0.4647 26.971 0.9059 non-Fickian diffusion 
p(AAPBA-b-OVZG)4 3 0.5447 28.513 0.9035 non-Fickian diffusion 
p(AAPBA-b-OVZG)5 3 0.4906 25.316 0.9591 non-Fickian diffusion 
 
CD spectroscopy was employed to evaluate the insulin conformational changes. The far-UV-CD 
band at 208 nm primarily arises from an α-helix structure, while the β-structure caused the band at 
223 nm. The changes in the ratio of [F]208/[F]223 can be used to evaluate any alterations in 
conformation. The ratio of [F]208/[F]223 was found to be 1.28 and 1.21 for standard insulin and 
released insulin, indicating that there was no significant conformational change observed for the 
insulin released from the NPs at pH 7.4 in contrast to standard insulin (Fig. 8). Furthermore, the 
spectral characteristics show that the release process did not distort the tertiary structure of insulin. 
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Fig.8. CD spectra of the insulin released from the nanoparticles and standard insulin in PBS at pH 7.4, 25 °C. 
 
3.5 Cytotoxicity testing  
Fig.9 shows the cytotoxicity of blank nanoparticles and p(AAPBA-b-OVZG) NPs as determined 
by the MTT method on NIH3T3 cell lines.  The NIH3T3 cells were exposed to suspensions of 
the NPs at concentrations varying from 20 to 120 ug/mL and the cells without pretreatment were 
set as a negative control group.  The relative cell viability of the samples was higher than 80% 
after incubating for 24 h, indicating that the presence of the glycopolymer had no negative 
influence on cell viability although the cell viability was the highest when the AAPBA content in 
the glycopolymer was the lowest.  Overall, those results suggested that the OVZG moieties in the 
polymers reduced the cytotoxicity and the presence of phenylboronic acid enhanced the 
glucose-sensitivity of the polymers. As a result, those nanoparticles have little cytotoxicity and 
favorable biocompatibility, indicating a potential application for insulin delivery in vivo.  
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Fig.9. Cell viability using the MTT assay at 37 oC after the incubation for 24 h as a function of the concentration of 
p(NVCL-co-AAPBA) NPs. Each value represents the mean±SD (n=5) 
 
3.6 Animal toxicity 
Before the nanoparticles are injected to animals or patients, cell and animal toxicity needs to be 
determined. Many studies have shown that PBA based co-polymers or nanogels have good 
cytocompatibility [39; 40] and our research is consistent with these reports. For animal toxicity, 
previous research has found that the PBA has a certain level of toxicity [41; 42], but if the PBA is 
incorporated into a copolymer, then the situation may change considerably.  Fig. 10 shows the 
testing results obtained from intraperitoneally injecting 100, 200 and 400 mg/kg/d of NPs 
according to the weight of the mice.  Silky hair was found to be present in all of the mice, there 
appeared to be good mental state and regular eating and drinking habits during 7 days observation. 
A total of 7 days later, all the mice were sacrificed; their livers, kidneys, hearts, spleens and lungs 
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were harvested for HE staining. It can be seen in Fig. 10 that the tissues were not obviously 
damaged, indicating that the prepared materials had no toxicity in vivo in short term.   
 
 
 
Fig.10. Representative images of HE staining results from (A) the control group; (B) the observation group 
(100mg); (C) the observation group (200mg); (D) the observation group (400mg) on (1) liver; (2) kidney; (3) 
lung; (4) spleen; (5) heart 
 
Also, in separate a chronic toxicity trial mice received intraperitoneal injections of 10, 20 and 40 
mg/kg/d of NPs respectively. These results demonstrate that the materials are safe and have no 
adverse influence on the blood biochemical values, indicating that the materials have no toxicity 
over at least 60 days in vivo (Table 6).  
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Tab.6. Effect of administration by injection of the NPs on the biochemical parameters of rats after 60 d (n=5, 
mean±SD) 
parameter Control Group 
Observation group(mg/kg) 
10 20 40 
RBC(×10
6
/uL) 2.85±0.23 2.92±0.19 2.89±0.20 2.94±0.23 
WBC(×10
3
/uL) 9.42±0.39 9.57±0.48 9.64±0.51 9.72±0.28 
Haemoglobin(g/dl) 14.44±1.19 14.62±1.70 14.58±1.18 14.52±1.19 
Haematocrit(vol.%) 36.57±1.22 36.76±1.29 36.57±1.39 36.68±1.38 
Platelet(×10
3
/uL)) 88.77±2.72 91.14±2.08 92.23±2.41 92.42±2.47 
Serum protein (g/l) 55.82±3.41 55.61±3.49 56.86±2.81 56.28±2.86 
Serum creatinine (mg/dl) 3.52±0.19 3.64±0.18 3.69±0.25 3.71±0.27 
Serum glutathione (mg/dl) 0.61±0.05 0.67±0.11 0.59±0.12 0.57±0.21 
Total cholesterol (mg/dl) 71.23±4.46 70.43±4.78 68.98±4.83 70.11±5.12 
Glucose (mg/dl) 262.43±9.05 259.26±8.34 258.17±9.12 251.21±8.75 
Uric acid (mg/dl) 5.19±0.69 5.24±0.58 5.29±0.59 5.31±0.61 
AST(U/l) 39.18±3.31 40.23±3.51 41.42±3.49 39.87±3.32 
ALT(U/l) 95.87±4.71 96.17±4.53 96.23±4.28 97.16±4.47 
 
3.7 In vivo hypoglycemic studies 
To date, much work has been carried out on rats or mice via oral administration of insulin loaded 
NPs.  Guo et al. [43] prepared the amphiphilic glycopolymer poly(D-gluconamidoethyl 
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methacrylate-random-3-acrylamidophenyl boronic acid) (p(GAMA-r-AAPBA)) and found there 
was a significant decrease in blood glucose levels after oral administration.  These results are 
consistent with those of Zhang et al. [44] and Sun et al. [45], who demonstrated that appropriately 
loaded oral nanoparticles can effectively lower blood sugar.  Other work by Wu et al. [40] 
reported that the nanogels of poly(N-isopropylacrylamide), dextran and 
poly(3-acrylamidophenylboronic acid) (p(NIPAM–Dex–PBA)) could decrease blood glucose 
levels in diabetic rats and 51% of the baseline level was maintained for almost 2 hours.  In the 
present study, the plasma of diabetes mice was periodically collected from the tail veins at 0, 1, 2, 
3, 4, 5, 6, 12, 24, 36, 48, 60, 72, 84, 96, 108 and 120 h in order to quantify glucose levels.  The 
results (Fig. 11A) reveal that the insulin-loaded NPs and insulin injection-treated mice had similar 
glucose levels from 0 h to 96 h, while the former showed a slight increase in blood glucose levels 
after 100 h.  This suggests that insulin-loaded NPs have a consistent hypoglycemic effect on the 
mice at least for 96 hours.  Additionally, Fig 11B indicates that the plasma glucose levels were 
rapidly downregulated in insulin injection-treated groups and insulin-loaded NPs groups and this 
is consistent with the studies mentioned above [21,40]. This demonstrates that AAPBA, as a part 
of the p(AAPBA-b-OVZG) polymer, shows excellent sensitivity to glucose and this effect is 
almost equivalent to that of insulin injection-treated groups over 96 h.  
After injecting the mice with the NPs, the released insulin can been used to determine the relative 
bioavailability [46, 47]. Lei et al. [48] manufactured a composite hydrogel system containing 
glucose-responsive nanocarriers for oral delivery of insulin and found the glucose-responsive 
nanocarriers can significantly prolong the time of insulin in the serum. In addition, Depeng et al. 
[49] fabricated a CaCO3-based composite nanocarrier and got the same results and similar studies 
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have also been conducted [50-52]. Fig.11C and Fig.11D shows that the insulin levels were about 
19~25 mIU/L in the control group and were about 10~15 mIU/L in the diabetic group indicating 
that both insulin injection treatment and the insulin-loaded NPs groups show a sharp increase in 
the plasma insulin concentration. Meanwhile, for the insulin injection treatment group, the highest 
value is seen after a short time (~2 h) and then decreases rapidly to a lower level within 4 h. In 
contrast, for the NPs group the plasma insulin concentration is increased to the highest value at 3h 
and then declined slowly to a lower level after 80 h. These results demonstrate that the 
insulin-loaded NPs have an obvious advantage compared with insulin injection. 
 
 
Fig.11. Blood glucose and serum insulin concentration after injection: A over 120 h and B over 6 h. (Fig.13 does 
not show the hypoglycemic effect within first six hours, so this is presented over 6 h in Fig.13B; Fig.13C is 
presented over 6 h in Fig.13D;).   
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4. Conclusions 
A novel amphiphilic block glycopolymer, p(AAPBA-b-OVZG) based on phenylboronic acid 
and 6-O-vinylazeloyl-D-galactose was synthesized. The Mw, Mn and PDI increased as the ratio of 
p(AAPBA) present was elevated in p(AAPBA-b-OVZG). The polymers have an ability to easily 
self-assemble into spherical NPs (50-250nm) which exhibited excellent glucose-sensitive behavior 
at physiological pH in vivo. In the presence of increasing glucose levels in solution the size of NPs 
became larger. Insulin was easily encapsulated into the NPs, with a high loading capacity of 10% 
and it was found that the release of insulin is in response to an increased glucose concentration. 
Moreover it was found that the glycopolymers have an ideal biocompatibility both in vitro and in 
vivo, indicating a potential application in the biomedical field as the persistent hypoglycemic 
effect of p(AAPBA-b-OVZG) NPs were effective over 96h. Taken together, this study suggests 
that promising glycopolymers based on p(AAPBA-b-OVZG) may be applied as an insulin 
delivery system in the future. 
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GRAPHICAL ABSTRACT 
 
 
 
Graphic abstract: Schematic representation of nanoparticles 
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Highlights 
1. A comprehensive study of p(AAPBA-b-OVZG) nanoparticles may also help to 
inspire future designs of insulin or other hypoglycemic protein delivery. 
2. p(AAPBA-b-OVZG) is convenient to carry out. 
3. p(AAPBA-b-OVZG) is low toxic and safe. 
4.The insulin-loaded p(AAPBA-b-OVZG) NPs have a consistent hypoglycemic effect 
on the mice at least 96 hours. 
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